| Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents AM Goldstein, M Chan, M Harland, NK Hayward, F Demenais, DT Bishop, ... Journal of medical genetics 44 (2), 99-106, 2007 | 525 | 2007 |
| High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL AM Goldstein, M Chan, M Harland, EM Gillanders, NK Hayward, MF Avril, ... Cancer research 66 (20), 9818-9828, 2006 | 505 | 2006 |
| Genome-wide association study identifies three new melanoma susceptibility loci JH Barrett, MM Iles, M Harland, JC Taylor, JF Aitken, PA Andresen, ... Nature genetics 43 (11), 1108-1113, 2011 | 293 | 2011 |
| Update in genetic susceptibility in melanoma M Potrony, C Badenas, P Aguilera, JA Puig-Butille, C Carrera, J Malvehy, ... Annals of translational medicine 3 (15), 2015 | 275 | 2015 |
| TERT Promoter Mutation Status as an Independent Prognostic Factor in Cutaneous Melanoma KG Griewank, R Murali, JA Puig-Butille, B Schilling, E Livingstone, ... Journal of the National Cancer Institute 106 (9), dju246, 2014 | 269 | 2014 |
| Benefits of total body photography and digital dermatoscopy (“two-step method of digital follow-up”) in the early diagnosis of melanoma in patients at high risk for melanoma G Salerni, C Carrera, L Lovatto, JA Puig-Butille, C Badenas, E Plana, ... Journal of the American Academy of Dermatology 67 (1), e17-e27, 2012 | 264 | 2012 |
| Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma MH Law, DT Bishop, JE Lee, M Brossard, NG Martin, EK Moses, F Song, ... Nature genetics 47 (9), 987-995, 2015 | 250 | 2015 |
| Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility MT Landi, DT Bishop, S MacGregor, MJ Machiela, AJ Stratigos, P Ghiorzo, ... Nature genetics 52 (5), 494-504, 2020 | 161 | 2020 |
| A variant in FTO shows association with melanoma risk not due to BMI J Randerson-Moor, C Requena, L Rivoltini, M Rodolfo, M Santinami, ... Nature genetics 45 (4), 428-432, 2013 | 135 | 2013 |
| The effect on melanoma risk of genes previously associated with telomere length MM Iles, DT Bishop, JC Taylor, NK Hayward, M Brossard, AE Cust, ... Journal of the National Cancer Institute 106 (10), dju267, 2014 | 134 | 2014 |
| Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways DL Duffy, G Zhu, X Li, M Sanna, MM Iles, LC Jacobs, DM Evans, S Yazar, ... Nature communications 9 (1), 4774, 2018 | 106 | 2018 |
| Increased prevalence of lung, breast, and pancreatic cancers in addition to melanoma risk in families bearing the cyclin-dependent kinase inhibitor 2A mutation: implications … M Potrony, JA Puig-Butillé, P Aguilera, C Badenas, C Carrera, J Malvehy, ... Journal of the American Academy of Dermatology 71 (5), 888-895, 2014 | 80 | 2014 |
| Cell-type–specific eQTL of primary melanocytes facilitates identification of melanoma susceptibility genes T Zhang, J Choi, MA Kovacs, J Shi, M Xu, AM Goldstein, AJ Trower, ... Genome research 28 (11), 1621-1635, 2018 | 77 | 2018 |
| Capturing the biological impact of CDKN2A and MC1R genes as an early predisposing event in melanoma and non melanoma skin cancer JA Puig-Butille, MJ Escámez, F Garcia-Garcia, G Tell-Marti, À Fabra, ... Oncotarget 5 (6), 1439, 2014 | 73 | 2014 |
| Genetic abnormalities in large to giant congenital nevi: beyond NRAS mutations VM da Silva, E Martinez-Barrios, G Tell-Martí, M Dabad, C Carrera, ... Journal of Investigative Dermatology 139 (4), 900-908, 2019 | 72 | 2019 |
| Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer A Prat, V Guarneri, T Pascual, F Braso-Maristany, E Sanfeliu, L Pare, ... EBioMedicine 75, 2022 | 67 | 2022 |
| Dermoscopic features of melanomas associated with MC1R variants in Spanish CDKN2A mutation carriers F Cuéllar, S Puig, I Kolm, J Puig‐Butille, P Zaballos, R Martí‐Laborda, ... British Journal of Dermatology 160 (1), 48-53, 2009 | 66 | 2009 |
| Genetic alterations in RAS‐regulated pathway in acral lentiginous melanoma JA Puig‐Butillé, C Badenas, Z Ogbah, C Carrera, P Aguilera, J Malvehy, ... Experimental dermatology 22 (2), 148-150, 2013 | 63 | 2013 |
| The MC1R melanoma risk variant p.R160W is associated with Parkinson disease G Tell‐Marti, JA Puig‐Butille, M Potrony, C Badenas, M Mila, J Malvehy, ... Annals of neurology 77 (5), 889-894, 2015 | 61 | 2015 |
| Prevalence and predictors of germline CDKN2A mutations for melanoma cases from Australia, Spain and the United Kingdom M Harland, AE Cust, C Badenas, YM Chang, EA Holland, P Aguilera, ... Hereditary cancer in clinical practice 12, 1-10, 2014 | 61 | 2014 |
